卡培他滨维持治疗：晚期宫颈癌预料之外的缓解和耐受性良好的方案
卡培他滨维持治疗：晚期宫颈癌预料之外的缓解和耐受性良好的方案——一个病例报告Maintenance therapy with capecitabine: unexpected remission of advanced cervical cancer and well tolerated regimen. A case repo
卡培他滨维持治疗：晚期宫颈癌预料之外的缓解和耐受性良好的方案——一个病例报告
Maintenance therapy with capecitabine: unexpected remission of advanced cervical cancer and well tolerated regimen. A case report
F. Amouzegar Hashemi1, N. Behtash2, S. Goodarzi2, S. Akhavan3
1Department of Radiation Oncology, Tehran University of Medical Science, Cancer Institut, 2Department of Gynecology Oncology, 3Tehran University of Medical Science, Tehran, Iran
Cervical cancer continues to be a significant health burden worldwide. Globally, the majority of cancers are locally advanced at diagnosis, hence, radiation remains the most frequently used therapeutical modality, however the prognosis of advanced stages is extremely poor and cure is rare. We present a case of persistent stage IIIb cervical cancer in which the patient remains disease-free about two years after beginning treatment with capacitabine(xeloda) 500mg twice daily every 2 weeks monthly. This is a well tolerated regimen without impairment in quality of life. In rare cases an unexpected complete clinical remission and long-term survival without evidence of disease may be achieved in patients with advanced, recurrent or metastatic cervical cancer treated with multimodal therapy.
更多精彩内容，请点击专题报道：http://zt.cmt.com.cn/zt/igcs2012/index.html
相关文章
评论
我要跟帖
